An AI tool developed by New York University could predict which COVID-19 patients will go on to contract acute respiratory distress syndrome, before any severe symptoms emerge.
A Chinese study of more than 1000 patients has found that chest CT outperformed lab testing in the diagnosis of COVID-19.
Many families spend years looking for a cause to the symptoms of a rare disease. A diagnosis gives families an answer and the ability to find support.
Professor Brendan Crabb received the 2019 GSK Award for Research Excellence for his research on malaria.
A list of up-and-coming technologies has been unveiled by the Cleveland Clinic, selected by a panel of Cleveland Clinic physicians and scientists.
Researchers have discovered how medications for Parkinson's disease cause some patients to develop addictive behaviours such as problem gambling, binge eating, hypersexuality and excessive shopping.
Tuberculosis (TB) can now be identified in less than an hour thanks to a new blood test.
A new class of diabetes medications is masking the potentially dangerous condition of ketoacidosis at the time of surgery, according to researchers.
The death rates of people with autism spectrum disorder are twice that of the general population. But their autism is not the primary cause of death.
The CareFit Slim LCD Cart is a documentation medical cart that works as a point-of-care solution at a patient's bedside, in a hallway or any other area with its slim depth and small footprint.
For most medical practitioners, choosing a new stethoscope can be an arduous task.
A new link between a thinning eye retina and dopamine means doctors may soon be able to diagnose Parkinson's disease with a simple eye scan.
A decade ago, lymphoma therapies for sick dogs were being trialled to help children with the disease. Now, cancer medication for humans is being successfully adapted to help man's best friend.
Professor Rakoczy has developed an innovative new gene therapy for age-related macular degeneration (AMD). We discuss her research and how she is using modified viruses as a delivery vehicle.
The osteomiR microRNA signature is intended to assess the risk of a first fracture in female patients of postmenopausal osteoporosis and type 2 diabetes. This information enables timely interventions and can help to avoid fractures.